In conclusion, AS-IV inhibited cell viability and glycolysis of HCC by regulating KAT2A-mediated succinylation of PGAM1, which might provide new insights into the treatment of in HCC. The gene discussed is PGAM1; the disease is hepatocellular carcinoma.